Mar 2024 $2 M Private placement after listing Under $2 million 1
Vaccinex, Inc.: Private sale, Mar 2024 × Investors in this round 1 investor had bought by the notice of Apr 12, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Elizabeth Evans · Executive Officer Ernest S. Smith, Ph.D. · Executive Officer Jill Sanchez · Executive Officer Maurice Zauderer, Ph.D. · Director, Executive Officer Albert D. Friedberg · Director Bala S. Manian, Ph.D. · Director Barbara Yanni · Director Chrystyna Bedrij Stecyk · Director Gerald E. Van Strydonck · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total remaining to be sold represents the aggregate exercise price of warrants to purchase shares of the Company's common stock.”Signed by Maurice Zauderer, Ph.D., President, CEO. Source: SEC Form D, newest notice filed Apr 12, 2024. Read the notice at the SEC .
equity, options SEC Mar 2024 $1 M Private placement after listing Under $2 million 3
Vaccinex, Inc.: Private sale, Mar 2024 × Investors in this round 3 investors had bought by the notice of Apr 12, 2024: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Elizabeth Evans · Executive Officer Ernest S. Smith, Ph.D. · Executive Officer Jill Sanchez · Executive Officer Maurice Zauderer, Ph.D. · Director, Executive Officer Albert D. Friedberg · Director Bala S. Manian, Ph.D. · Director Barbara Yanni · Director Chrystyna Bedrij Stecyk · Director Gerald E. Van Strydonck · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total remaining to be sold represents the aggregate exercise price of warrants to purchase shares of the Company's common stock.”Signed by Maurice Zauderer, Ph.D., President, CEO. Source: SEC Form D, newest notice filed Apr 12, 2024. Read the notice at the SEC .
equity, options SEC Sep 2020 $2 M Private placement after listing $2 to $10 million 1
Vaccinex, Inc.: Private sale, Sep 2020 × Investors in this round 1 investor had bought by the notice of Sep 16, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ernest S. Smith · Executive Officer Maurice Zauderer · Executive Officer, Director Raymond E. Watkins · Executive Officer Scott E. Royer · Executive Officer Albert D. Friedberg · Director Bala S. Manian · Director Barbara E. Yannni · Director Chrystyna D. Bedrij Stecyk · Director Gerald E. Van Strydonck · Director J. Jeffrey Goater · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Royer, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 16, 2020. Read the notice at the SEC .
equity SEC Jul 2020 $4 M Private placement after listing $2 to $10 million 1
Vaccinex, Inc.: Private sale, Jul 2020 × Investors in this round 1 investor had bought by the notice of Jul 15, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ernest S. Smith · Executive Officer Maurice Zauderer · Executive Officer, Director Raymond E. Watkins · Executive Officer Scott E. Royer · Executive Officer Albert D. Friedberg · Director Alejandro M. Berlin · Director Bala S. Manian · Director Barbara E. Yanni · Director Chrystyna E. Bedrij Stecyk · Director Gerald E. Van Strydonck · Director J. Jeffrey Goater · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Royer, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 15, 2020. Read the notice at the SEC .
equity SEC Jan 2020 $7 M Private placement after listing $2 to $10 million 5
Vaccinex, Inc.: Private sale, Jan 2020 × Investors in this round 5 investors had bought by the notice of Feb 3, 2020: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ernest S. Smith · Executive Officer Maurice Zauderer · Executive Officer, Director Raymond E. Watkins · Executive Officer Scott E. Royer · Executive Officer Albert D. Friedberg · Director Alejandro M. Berlin · Director Bala S. Manian · Director Barbara E. Yanni · Director Gerald E. Van Strydonck · Director J. Jeffrey Goater · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Royer, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 3, 2020. Read the notice at the SEC .
equity SEC Jul 2019 $14 M Private placement after listing $10 to $50 million 5
Vaccinex, Inc.: Private sale, Jul 2019 × Investors in this round 5 investors had bought by the notice of Aug 14, 2019: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $14 M of $14 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ernest S. Smith · Executive Officer Maurice Zauderer · Executive Officer, Director Raymond E. Watkins · Executive Officer Scott E. Royer · Executive Officer Albert D. Friedberg · Director Alejandro M. Berlin · Director Bala S. Manian · Director Barbara E. Yanni · Director Gerald E. Van Strydonck · Director J. Jeffrey Goater · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Royer, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 14, 2019. Read the notice at the SEC .
equity SEC May 2017 $6 M No. 1 $2 to $10 million 1
Vaccinex, Inc.: Raise no. 1, May 2017 × Investors in this round 1 investor had bought by the notice of Jul 7, 2017: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Vaccinex, Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $18 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ernest S. Smith · Executive Officer John E. Leonard · Executive Officer Maurice Zauderer · Executive Officer, Director Raymond E. Watkins · Executive Officer Steven P. Cobourn · Executive Officer Alan L. Crane · Director Albert D. Friedberg · Director Alejandro M. Berlin · Director Bala S. Manian · Director Barbara E. Yanni · Director Gerald E. Van Strydonck · Director J. Jeffrey D. Goater · Director Jacob B. Frieberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steven P Cobourn, Cfo. Source: SEC Form D, newest notice filed Jul 7, 2017. Read the notice at the SEC .
equity SEC